|
||||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: ENSG00000099864 |
Summary for PALM |
Gene summary |
| Gene information | Ensembl ID | ENSG00000099864 | Gene symbol | PALM |
| Gene name | paralemmin | |
| HGNC | 8594 | |
| Entrez ID | 5064 | |
| Gene type | protein_coding | |
| Synonyms | PALM|KIAA0270|PALM1 | |
| UniProtAcc | O75781 |
Drugs associated with this gene(DrugBank). |
| Gene ID | Gene Symbol | Drug ID | Drug Name | Drug Type |
Cancer therapeutic drugs associated with this gene(NCI). |
| Gene ID | Gene Name | Drug ID | Drug Name | Drug Type | Cancer |
Top |
Structure and expression level for PALM |
AS events and RNA A-to-I editing events of the gene in TCGA based on Genvode V22 structure.∗For more information on exon skipping events please check the ExonskipDB database. ∗For more information on exon skipping events please check the CAeditome database. |
Landscape of gene expressions across multiple cancer types. |
Differentially expressed gene analysis between tumor male and tumor female samples. |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
Differentially expressed gene analysis between tumor male and normal male samples. |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
| PALM | 7.12e+02 | -1.55e+00 | 5.60e-01 | -2.76e+00 | 5.72e-03 | 1.48e-02 | BLCA |
| PALM | 2.81e+03 | -1.23e+00 | 2.17e-01 | -5.67e+00 | 1.39e-08 | 6.66e-08 | KIRP |
Differentially expressed gene analysis between tumor female and normal female samples. |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
| PALM | 9.36e+02 | -1.02e+00 | 1.72e-01 | -5.93e+00 | 3.03e-09 | 1.25e-08 | LUAD |
| PALM | 5.43e+02 | -1.47e+00 | 3.71e-01 | -3.97e+00 | 7.12e-05 | 4.35e-04 | HNSC |
| PALM | 9.66e+02 | 1.49e+00 | 3.60e-01 | 4.12e+00 | 3.71e-05 | 1.32e-04 | LIHC |
| PALM | 2.24e+03 | -1.37e+00 | 1.13e-01 | -1.21e+01 | 5.96e-34 | 3.52e-33 | BRCA |
| PALM | 3.54e+02 | -2.11e+00 | 4.19e-01 | -5.04e+00 | 4.67e-07 | 4.52e-06 | READ |
Top |
Sex-biased somatic mutation for PALM |
| ∗For more information on exon skipping events please check the ExonskipDB database. |
| Gene ID | Cancer Type | Hugo Symbol | Male | Female | pval | or | ci.up | ci.low | adjPval |
Top |
DNA methylation with beta values for PALM |
Landscape of DNA methylation across multiple cancer types. |
Differentially expressed CpG sites between male tumor and female tumor patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| BRCA | cg16019612 | chr19:708568 | CGI:chr19:708530-708742 | promoter | 3.07e-01 | 1.75e-01 | 3.10e+00 | 1.94e-03 | 1.34e-02 | 1.32e-01 |
| BRCA | cg01799015 | chr19:707791 | CGI:chr19:708530-708742 | promoter | 3.98e-01 | 2.74e-01 | 3.35e+00 | 8.21e-04 | 8.38e-03 | 1.23e-01 |
| BRCA | cg04427490 | chr19:708469 | CGI:chr19:708530-708742 | promoter | 3.68e-01 | 2.58e-01 | 2.56e+00 | 1.03e-02 | 2.70e-02 | 1.10e-01 |
Differentially expressed CpG sites between male tumor and male normal patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| KIRC | cg01799015 | chr19:707791 | CGI:chr19:708530-708742 | promoter | 4.52e-01 | 5.52e-01 | -4.36e+00 | 1.29e-05 | 3.40e-05 | -1.01e-01 |
| COAD | cg18253101 | chr19:709325 | CGI:chr19:709227-709990 | promoter,gene body | 2.28e-01 | 2.29e-02 | 3.48e+00 | 5.08e-04 | 1.30e-03 | 2.05e-01 |
| BLCA | cg16019612 | chr19:708568 | CGI:chr19:708530-708742 | promoter | 4.81e-01 | 3.44e-01 | 2.56e+00 | 1.03e-02 | 1.45e-02 | 1.36e-01 |
| BLCA | cg23473819 | chr19:708670 | CGI:chr19:708530-708742 | promoter | 2.41e-01 | 8.87e-02 | 2.58e+00 | 9.99e-03 | 1.41e-02 | 1.52e-01 |
| BLCA | cg05913684 | chr19:710906 | CGI:chr19:710822-711066 | promoter,gene body | 4.56e-01 | 5.65e-01 | -2.39e+00 | 1.67e-02 | 2.12e-02 | -1.08e-01 |
| BLCA | cg27109482 | chr19:708643 | CGI:chr19:708530-708742 | promoter | 2.59e-01 | 1.42e-01 | 2.06e+00 | 3.92e-02 | 4.14e-02 | 1.17e-01 |
| BLCA | cg24027937 | chr19:709809 | CGI:chr19:709227-709990 | promoter,gene body | 2.56e-01 | 1.02e-01 | 2.51e+00 | 1.20e-02 | 1.63e-02 | 1.54e-01 |
| BLCA | cg20631351 | chr19:711001 | CGI:chr19:710822-711066 | promoter,gene body | 4.93e-01 | 5.97e-01 | -2.16e+00 | 3.12e-02 | 3.46e-02 | -1.04e-01 |
| KIRP | cg01799015 | chr19:707791 | CGI:chr19:708530-708742 | promoter | 3.97e-01 | 4.98e-01 | -3.56e+00 | 3.75e-04 | 7.94e-04 | -1.01e-01 |
| KIRP | cg00174901 | chr19:709889 | CGI:chr19:709227-709990 | promoter,gene body | 4.35e-01 | 2.96e-01 | 2.93e+00 | 3.42e-03 | 5.16e-03 | 1.38e-01 |
| ESCA | cg04427490 | chr19:708469 | CGI:chr19:708530-708742 | promoter | 5.25e-01 | 3.81e-01 | 2.80e+00 | 5.12e-03 | 3.43e-02 | 1.44e-01 |
| CHOL | cg05913684 | chr19:710906 | CGI:chr19:710822-711066 | promoter,gene body | 8.03e-01 | 6.82e-01 | 2.51e+00 | 1.22e-02 | 2.39e-02 | 1.21e-01 |
| CHOL | cg24027937 | chr19:709809 | CGI:chr19:709227-709990 | promoter,gene body | 3.91e-01 | 1.33e-01 | 2.29e+00 | 2.23e-02 | 3.24e-02 | 2.59e-01 |
| CHOL | cg00174901 | chr19:709889 | CGI:chr19:709227-709990 | promoter,gene body | 3.23e-01 | 2.03e-01 | 1.99e+00 | 4.65e-02 | 4.65e-02 | 1.19e-01 |
Differentially expressed CpG sites between female tumor and female normal patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| BRCA | cg05913684 | chr19:710906 | CGI:chr19:710822-711066 | promoter,gene body | 7.17e-01 | 5.00e-01 | 1.20e+01 | 2.52e-33 | 5.71e-32 | 2.16e-01 |
| BRCA | cg24027937 | chr19:709809 | CGI:chr19:709227-709990 | promoter,gene body | 3.52e-01 | 1.01e-01 | 1.01e+01 | 4.55e-24 | 3.54e-23 | 2.51e-01 |
| BRCA | cg00174901 | chr19:709889 | CGI:chr19:709227-709990 | promoter,gene body | 4.01e-01 | 2.18e-01 | 9.01e+00 | 1.99e-19 | 1.02e-18 | 1.83e-01 |
| BRCA | cg19925025 | chr19:710823 | CGI:chr19:710822-711066 | promoter,gene body | 8.28e-01 | 7.09e-01 | 1.08e+01 | 2.57e-27 | 2.75e-26 | 1.19e-01 |
| BRCA | cg20631351 | chr19:711001 | CGI:chr19:710822-711066 | promoter,gene body | 6.86e-01 | 5.06e-01 | 1.15e+01 | 2.12e-30 | 3.25e-29 | 1.81e-01 |
| LUAD | cg05913684 | chr19:710906 | CGI:chr19:710822-711066 | promoter,gene body | 6.77e-01 | 5.17e-01 | 3.70e+00 | 2.19e-04 | 1.27e-03 | 1.61e-01 |
| HNSC | cg05913684 | chr19:710906 | CGI:chr19:710822-711066 | promoter,gene body | 5.10e-01 | 3.82e-01 | 2.43e+00 | 1.50e-02 | 2.33e-02 | 1.28e-01 |
| HNSC | cg19925025 | chr19:710823 | CGI:chr19:710822-711066 | promoter,gene body | 6.54e-01 | 5.40e-01 | 2.22e+00 | 2.66e-02 | 3.29e-02 | 1.15e-01 |
| COAD | cg01799015 | chr19:707791 | CGI:chr19:708530-708742 | promoter | 4.33e-01 | 5.36e-01 | -2.45e+00 | 1.43e-02 | 2.04e-02 | -1.03e-01 |
| LIHC | cg00174901 | chr19:709889 | CGI:chr19:709227-709990 | promoter,gene body | 3.52e-01 | 2.06e-01 | 2.13e+00 | 3.29e-02 | 3.59e-02 | 1.46e-01 |
Top |
Exon skipping events with PSI in TCGA for PALM |
| ∗Please access ExonSkipDB for exon skipping annotation. |
Landscape of exon skipping events across multiple cancer types. |
Differentially expressed exon skipping events between male tumor and female tumor patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
Differentially expressed exon skipping events between male tumor and male normal patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
Differentially expressed exon skipping events between female tumor and female normal patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
| BRCA | exon_skip_300212 | 6.99e-01 | 9.32e-01 | -1.03e+01 | 1.03e-24 | 3.43e-23 | -2.32e-01 |
Top |
RNA A-to-I editing events in TCGA for PALM |
| ∗Please access CAeditome for RNA editing annotation. |
Differentially expressed RNA editing events between male tumor and female tumor patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
Differentially expressed RNA editing events between male tumor and male normal patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
Differentially expressed RNA editing events between female tumor and female normal patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
Protein coding RNA editing(s). |
| Editing Position | Variant Type | Gene Symbol | Transcript ID | NTchange | AAchange |
Top |
Sex-biased TF-Gene network for PALM |
TFs related to PALM.∗The female-biased TF-gene edges were identified if Female_Edge_threshold>0.98 and Male_Edge_threshold<=0.98. ∗The male-biased TF-gene edges were identified if Male_Edge_threshold>0.98 and Female_Edge_threshold<=0.98. |
| Cancer Type | TF | Target Gene | Male Edge Score | Male Edge Threshold | Female Edge Score | Female Edge Threshold | Type |
PALM related gene.∗Only the gene encode TF might with this result. ∗For more information please check Sex-biased TF-Coding gene network. |
Top |
Sex-biased RBP-ES network for PALM |
RBPs related to ES in PALM.∗The female-biased RBP-ES edges were identified if Female_Edge_threshold>0.98 and Male_Edge_threshold<=0.98. ∗The male-biased RBP-ES edges were identified if Male_Edge_threshold>0.98 and Female_Edge_threshold<=0.98. |
| Cancer Type | RBP | Target ES | Male Edge Score | Male Edge Threshold | Female Edge Score | Female Edge Threshold | Type |
| BRCA | SAMD4A | exon_skip_300207 | 6.28e+00 | 3.66e-03 | 7.21e+00 | 9.84e-01 | Female-biased |
| LGG | SAMD4A | exon_skip_300207 | 6.85e+00 | 9.83e-01 | 6.39e+00 | 2.54e-03 | Male-biased |
| GBM | SAMD4A | exon_skip_300207 | 6.71e+00 | 9.82e-01 | 6.21e+00 | 1.91e-03 | Male-biased |
| KIRC | RBM5 | exon_skip_300207 | 6.79e+00 | 6.50e-03 | 7.14e+00 | 9.81e-01 | Female-biased |
PALM related ES.∗Only the gene encode RBP might with this result. ∗For more information please check Sex-biased RBP-ES network in cancer. |
Top |
Sex-biased CeRNA regulation of gene |
Sex-biased CeRNA regulation of gene. |
| Gene ID | ceRNA(lncRNA-miRNA-mRNA) | Group | Cancer Type |
| ENSG00000099864 | CACNA1C-AS1,hsa-mir-665,PALM | Male-specific ceRNA | TCGA-BLCA |
| ENSG00000099864 | AC006116.6,hsa-mir-665,PALM | Male-specific ceRNA | TCGA-KIRP |
| ENSG00000099864 | HAGLR,hsa-mir-665,PALM | Male-specific ceRNA | TCGA-KIRP |
| ENSG00000099864 | AC106795.2,hsa-mir-665,PALM | Male-specific ceRNA | TCGA-KIRP |
| ENSG00000099864 | AC243965.2,hsa-mir-6748,PALM | Male-specific ceRNA | TCGA-KIRP |
| ENSG00000099864 | AC006116.6,hsa-mir-6748,PALM | Male-specific ceRNA | TCGA-KIRP |
| ENSG00000099864 | AP001062.1,hsa-mir-485,PALM | Female-specific ceRNA | TCGA-LIHC |
Top |
Sex-biased eQTL regulation of gene |
Sex-biased eQTL regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| eQTL | Description |
Male-specific eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Effect Score | FDR | Cancer Type | Biased Type |
Female-specific eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Effect Score | FDR | Cancer Type | Biased Type |
| rs892084 | chr19:10558356:T:C | - | -0.0815701041501938 | 0.0432345920202799 | LUAD | Male-baised eQTL |
| rs7249872 | chr19:7298581:C:G | - | -0.106849982396698 | 0.0219269314956495 | COAD | Male-baised eQTL |
| rs1019757 | chr19:8324636:C:T | - | 0.0578169285135667 | 0.0234325993582423 | COAD | Male-baised eQTL |
| rs8101064 | chr19:7293108:T:C | - | -0.101811114770681 | 0.0299428219172368 | COAD | Male-baised eQTL |
| rs79342923 | chr19:10494960:G:T | - | 0.0672783402904051 | 0.0460485263934897 | COAD | Male-baised eQTL |
Opposite sex-biased eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Male Effect | Male FDR | Female Effect | Female FDR | Sex-biased Gene in Cancer | Cancer Type |
Top |
Sex-biased eQTM regulation of gene |
Sex-biased eQTM regulation of gene (The figures only show the pairs with FDR<1e-5. For more information please check the below table). |
Male-specific eQTM regulation. |
| CpG Site | CpG Postion | Position to Gene | Effect Score | FDR | Cor.r | Cor.Pvalue | Cancer Type |
Female-specific eQTM regulation. |
| CpG Site | CpG Postion | Position to Gene | Effect Score | FDR | Cor.r | Cor.Pvalue | Cancer Type |
| cg14695566 | chr19:720793 | gene | -0.191080629580317 | 7.0407339587659e-05 | -0.6207378927094095 | 1.634830427166828e-08 | LAML |
| cg04427490 | chr19:708469 | promoter | -0.463612265963467 | 2.56088687662011e-25 | -0.8998411548757846 | 7.869109164103897e-30 | PAAD |
| cg20631351 | chr19:711001 | gene,promoter | -0.463612265963467 | 2.56088687662011e-25 | -0.8998411548757846 | 7.869109164103897e-30 | PAAD |
| cg05913684 | chr19:710906 | gene,promoter | -0.436734959549425 | 7.57081757564327e-15 | -0.4218663426165742 | 2.5927666687362896e-17 | THCA |
Opposite sex-biased eQTM regulation. |
| CpG Site | CpG Postion | CpG Island | Position to Gene | Male Effect | Male FDR | Female Effect | Female FDR | Male Cor | Male P-value | Female Cor | Female P-value | Sex-biased Coding Gene | Cancer Type |
Top |
Sex-biased sQTL regulation of gene |
Sex-biased sQTL regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| sQTL | Description |
Male-specific sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Effect Score | FDR | Cancer Type | Biased Type |
Female-specific sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Effect Score | FDR | Cancer Type | Biased Type |
| exon_skip_300212 | chr19:740351:740483 | In-frame | rs1683565 | chr19:880602:A:G | Distant downstream | -0.0298913565840175 | 0.0178236295619295 | KIRC | Male-baised sQTL |
| exon_skip_300212 | chr19:740351:740483 | In-frame | rs2930891 | chr19:883224:A:G | Distant downstream | -0.0296917443501666 | 0.0237223607826179 | KIRC | Male-baised sQTL |
| exon_skip_300212 | chr19:740351:740483 | In-frame | rs4417648 | chr19:883725:A:G | Distant downstream | -0.0296917443501666 | 0.0237223607826179 | KIRC | Male-baised sQTL |
| exon_skip_300212 | chr19:740351:740483 | In-frame | rs2930898 | chr19:883968:T:C | Distant downstream | -0.0296917443501666 | 0.0237223607826179 | KIRC | Male-baised sQTL |
| exon_skip_300212 | chr19:740351:740483 | In-frame | rs111310751 | chr19:878159:G:C | Distant downstream | -0.0292059388546297 | 0.027165198913174 | KIRC | Male-baised sQTL |
| exon_skip_300212 | chr19:740351:740483 | In-frame | rs2629996 | chr19:878598:C:T | Distant downstream | -0.0298987748729411 | 0.0280329992663131 | KIRC | Male-baised sQTL |
| exon_skip_300212 | chr19:740351:740483 | In-frame | rs1683566 | chr19:880560:G:A | Distant downstream | -0.0290258284955078 | 0.0290835676966056 | KIRC | Male-baised sQTL |
| exon_skip_300212 | chr19:740351:740483 | In-frame | rs2930894 | chr19:881161:G:A | Distant downstream | -0.0276097189351312 | 0.0450690325591494 | KIRC | Male-baised sQTL |
Opposite sex-biased sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Male Effect | Male FDR | Female Effect | Female FDR | Cancer Type |
Top |
Sex-biased sQTM regulation of gene |
Sex-biased sQTM regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| sQTM | Description |
| EX ID: exon_skip_300212 | |
| CpG Site: cg08617160 | |
| Position to EX: Distant upstream | |
| Male Effect: 0.20983888620025 | |
| Female Effect: - |
Male-specific sQTM regulation. |
| EX ID | Skipped Exon | CPG Site | CPG Position | Position to EX Events | Effect Score | FDR | Cor.r | Cor.Pvalue | ORF_anno | Cancer Type |
| exon_skip_300212 | chr19:740351:740483 | cg08617160 | chr19:345312 | Distant upstream | 0.20983888620025 | 9.66903586581739e-07 | 0.380770984677842 | 0.00045359947796893554 | In-frame | PAAD |
Female-specific sQTM regulation. |
| EX ID | Skipped Exon | CPG Site | CPG Position | Position to EX Events | Effect Score | FDR | Cor.r | Cor.Pvalue | ORF_anno | Cancer Type |
Opposite sex-biased sQTM regulation. |
| EX ID | EX Info | Skipped Exon | CPG Site | CPG Position | CPG Island | Position to EX Events | Male Effect | Male FDR | Female Effect | Female FDR | Male Correlation | Male P-value | Female Correlation | Female P-value | ORF_anno | Cancer Type |
Top |
Related disease information of PALM |
Diseases associated with this gene (DisGeNET). |
| Gene ID | Gene Symbol | Disease ID | Disease Name | Number of PMID | Source |